| Kristina St Clair, MD | |
|
1500 Oglethorpe Ave, Bldg, 600 Ste Cd, Athens, GA 30606-2179 | |
| (706) 559-4188 | |
| Not Available |
| Full Name | Kristina St Clair |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1500 Oglethorpe Ave, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366460768 | NPI | - | NPPES |
| 000791227A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 045631 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristina St Clair, MD 1500 Oglethorpe Ave, Bldg, 600 Ste Cd, Athens, GA 30606-2179 Ph: (706) 559-4188 | Kristina St Clair, MD 1500 Oglethorpe Ave, Bldg, 600 Ste Cd, Athens, GA 30606-2179 Ph: (706) 559-4188 |
News Archive
Two studies published in the journals PLOS Medicine and BMC Medicine in March 2020 show that obesity in childhood is linked to a higher risk of future anxiety, depression, and death in early adult life compared to children in the general population. This could shape efforts to detect specific risk factors that predispose children to obesity and thus prevent it.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved in endocrine therapy resistance in human breast cancer cells. Furthermore, resveratrol, a kind of polyphenol, was found to repress these RNAs and inhibit the proliferative activity of breast cancer cells which had acquired resistance.
› Verified 5 days ago
James Nicholas Frisk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 125 Telfair Pl, Athens, GA 30606 Phone: 706-548-2454 | |
Victor Morales, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-389-3000 Fax: 706-389-3839 | |
Charles F Potter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-769-0005 | |
Dr. Ashley Marie Bohn, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 600ef, Athens, GA 30606 Phone: 706-613-5980 | |
Nancy C Hendrix, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-353-1604 | |
Dr. Eugene Brannon Morris Iii, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1086 1/2 Baxter St, Athens, GA 30606 Phone: 706-353-0606 Fax: 706-353-0798 | |
Rajiv K Setia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 225 Hawthorne Park, Athens, GA 30606 Phone: 706-613-6136 Fax: 706-543-0706 |